Moderna's mRNA flu shot moves to FDA review after dispute resolution
TL;DR
Moderna says the FDA will review its experimental mRNA-based flu vaccine after resolving a public dispute, signaling movement toward potential regulatory consideration of the shot.
- Moderna says the FDA will consider its new flu shot after resolving a public dispute AP News
- FDA reverses course, will review Moderna's mRNA flu vaccine NBC News
- Opinion | Kennedy’s MAHA Coalition Is a Mess The New York Times
- FDA's reversal on Moderna flu shot bid followed White House pressure Politico
- U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says PBS
Want the full story? Read the original reporting
Read on AP News